| 20% PROSOL (2.06 G) | 02141450 | Marketed | Baxter Corporation | Jan 2015 |
| AVL ELECTROLYTE POWDER (6.756 G) | 02384248 | Marketed | Alberta Veterinary Laboratories Ltd | Nov 2024 |
| AVL ELECTROLYTE POWDER HE (6.756 G) | 02408309 | Marketed | Alberta Veterinary Laboratories Ltd | May 2024 |
| CALF-LYTE II (6.756 G) | 02242113 | Marketed | Vetoquinol N A Inc | Sep 2000 |
| CALF-LYTE II HE (6.756 G) | 02242114 | Marketed | Vetoquinol N A Inc | Sep 2000 |
| CALF-QUENCH HE (6.756 G) | 02495775 | Marketed | Dominion Veterinary Laboratories Ltd. | Oct 2025 |
| CLINIMIX (1.04 G) | 02013886 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (1.04 G) | 02013940 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (1040 MG) | 02046709 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (1.04 G) | 02013932 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (618 MG) | 02498448 | Marketed | Baxter Corporation | Apr 2022 |
| CLINIMIX (824 MG) | 02498456 | Marketed | Baxter Corporation | Apr 2023 |
| CLINIMIX (824 MG) | 02498464 | Marketed | Baxter Corporation | Nov 2020 |
| CLINIMIX E (1.04 G) | 02014076 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (1.04 G) | 02013967 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (515 MG) | 02142384 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (824 MG) | 02498413 | Marketed | Baxter Corporation | Oct 2021 |
| CLINIMIX E (824 MG) | 02498421 | Marketed | Baxter Corporation | Dec 2020 |
| ESSEPNA (1.1 G) | 02510324 | Marketed | Fresenius Kabi Canada Ltd | Jan 2023 |
| GLYCINE 1.5% IRRIGATION USP SOL (1.5 G) | 00799955 | Marketed | Baxter Corporation | Dec 1989 |
| GLYCINE IRRIGATION USP (15 MG) | 00498793 | Marketed | Icu Medical Canada Inc | Feb 2020 |
| OLIMEL 5.7% (3.95 G) | 02352540 | Marketed | Baxter Corporation | Sep 2019 |
| OLIMEL 5.7% E (3.95 G) | 02352532 | Marketed | Baxter Corporation | Jan 2011 |
| OLIMEL 7.6% (5.26 G) | 02477947 | Marketed | Baxter Corporation | Jul 2021 |
| OLIMEL 7.6% E (5.26 G) | 02477955 | Marketed | Baxter Corporation | Oct 2018 |
| PERIOLIMEL 2.5% E (1.76 G) | 02352494 | Marketed | Baxter Corporation | Feb 2011 |
| PH 12 STERILE DILUENT FOR FLOLAN (94 MG) | 02443651 | Marketed | Glaxosmithkline Inc | Aug 2016 |
| PRIMENE 10% (400 MG) | 02236875 | Marketed | Baxter Corporation | Dec 2014 |
| SMOFKABIVEN (0.56 G) | 02440695 | Marketed | Fresenius Kabi Canada Ltd | Sep 2015 |
| SMOFKABIVEN ELECTROLYTE FREE (0.56 G) | 02440687 | Marketed | Fresenius Kabi Canada Ltd | Sep 2015 |
| SMOFKABIVEN EXTRA NITROGEN (0.72 G) | 02501813 | Marketed | Fresenius Kabi Canada Ltd | May 2021 |
| SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE (0.72 G) | 02501775 | Marketed | Fresenius Kabi Canada Ltd | Jul 2021 |
| SMOFKABIVEN PERIPHERAL (350 MG) | 02456206 | Marketed | Fresenius Kabi Canada Ltd | Feb 2017 |
| TRAVASOL (1.03 G) | 00872296 | Marketed | Baxter Corporation | Oct 2013 |
| V-LYTES (WATER SOLUBLE ELECTROLYTE POWDER) (6.006 G) | 02047519 | Marketed | Vetoquinol N A Inc | Dec 1993 |
| V-LYTES HE (WATER SOLUBLE NUTRIENT, ELECTROLYTE POWDER FOR ORAL USE IN CALVES) (6.006 G) | 01957341 | Marketed | Vetoquinol N A Inc | Jul 2007 |
| AMINO BOLUSES IMPROVED (435 MG) | 00319333 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| AMINOLEAN INJECTION (0.6 MG) | 00506990 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| AMINOSYN II (500 MG) | 00742619 | Dormant | Icu Medical Canada Inc | Aug 2018 |
| AMINOSYN II (750 MG) | 02126745 | Dormant | Icu Medical Canada Inc | Sep 2018 |
| CALF-QUENCH (6.756 G) | 02495767 | Approved | Dominion Veterinary Laboratories Ltd. | Jan 2020 |
| REVIBE (6.006 G) | 00859613 | Dormant | Phibro Animal Health Corporation | May 2026 |
| REVIBE H.E. (6.006 G) | 00890006 | Dormant | Phibro Animal Health Corporation | May 2026 |
| SOLYTES POWDER (6.756 G) | 02542412 | Approved | Alberta Veterinary Laboratories Ltd | Oct 2023 |
| SOLYTES POWDER HE (6.756 G) | 02548348 | Approved | Alberta Veterinary Laboratories Ltd | May 2024 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (260 MG) | 02143267 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX (520 MG) | 02013975 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 10% DEXTROSE QUICKMIX (520 MG) | 02014106 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX (260 MG) | 02143259 | Cancelled Post Market | Clintec Nutrition Company | Aug 1998 |
| 2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX (283 MG) | 02143232 | Cancelled Post Market | Clintec Nutrition Company | Aug 1998 |
| 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX (570 MG) | 02014009 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX (570 MG) | 02013991 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. (283 MG) | 02143240 | Cancelled Post Market | Clintec Nutrition Company | Aug 1999 |
| 4.25% AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE QUICKMIX (880 MG) | 02013908 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (438 MG) | 02142414 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (438 MG) | 02142406 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX (880 MG) | 02014033 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE (438 MG) | 02142392 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX (880 MG) | 02014017 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE (438 MG) | 02142317 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE (438 MG) | 02142309 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE (438 MG) | 02142295 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 4.25% TRAVASOL AMINO ACID WITHOUT ELECTROLYTES IN 5% DEXTROSE QUICKMIX (880 MG) | 02013894 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25%TRAV. AMINO ACID INJ.W.O.ELECT.5%DEXT. (438 MG) | 02142325 | Cancelled Post Market | Clintec Nutrition Company | Aug 1999 |
| 4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. (438 MG) | 02143224 | Cancelled Post Market | Clintec Nutrition Company | Aug 1999 |
| 5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (515 MG) | 02142368 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE (515 MG) | 02142252 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE (515 MG) | 02142244 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 8.5% FREAMINE III (1.19 G) | 02158647 | Cancelled Post Market | B. Braun Medical AG | Apr 2012 |
| AMINO ACID FORMULA INJ (6.7 MG) | 00508365 | Cancelled Post Market | Central Sales Limited | Jul 2002 |
| AMINO ACID FORMULA INJ (6.7 MG) | 00583537 | Cancelled Post Market | Centravet Products | Aug 1996 |
| AMINO ACID INJECTABLE (1.2 MG) | 00626368 | Cancelled Post Market | Univet Pharmaceuticals Ltd. | Jun 2023 |
| AMINO-JUG (0.6 MG) | 02283514 | Cancelled Post Market | Wyeth Animal Health, Division Of Wyeth Canada | Jul 2008 |
| AMINODERM POUDRE (10 MG) | 00086649 | Cancelled Post Market | Desbergers Ltée, Division Of Technilab Inc. | Aug 2004 |
| AMINOSYN (1280 MG) | 00454907 | Cancelled Post Market | Icu Medical Canada Inc | Jan 2019 |
| AMINOSYN 10% W ELECTROLYTES (1.28 G) | 00558966 | Cancelled Post Market | Abbott Laboratories Co. | Aug 1999 |
| AMINOSYN 3.5% M (448 MG) | 00510629 | Cancelled Post Market | Abbott Laboratories Co. | Aug 1999 |
| AMINOSYN 5% (640 MG) | 00404160 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN 7% (900 MG) | 00523232 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN 8.5% (1.1 G) | 00613320 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN 8.5% INJECTION WITH ELECTROLYTES (1.1 G) | 00613339 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II 10% WITH ELECTROLYTES (500 MG) | 00742651 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN II 5% INJ (250 MG) | 00742643 | Cancelled Post Market | Abbott Laboratories Co. | Aug 1999 |
| AMINOSYN II 7% INJECTION (350 MG) | 00742635 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN II 7% M IN 10% DEXTROSE(DUAL CHAMBER) (175 MG) | 00742724 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II 7% WITH 10% DEXTROSE (175 MG) | 00742740 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II 7% WITH 50% DEXTROSE (175 MG) | 00742759 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II 8.5% INJECTION (425 MG) | 00742627 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER) (212 MG) | 00742716 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II 8.5% WITH 50% DEXTROSE (212 MG) | 00742767 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II IN DEXTROSE INJECTION (250 MG) | 00742783 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II IN DEXTROSE INJECTION (212 MG) | 00839302 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II IN DEXTROSE INJECTION (212 MG) | 00839310 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM (212 MG) | 00851531 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM (212 MG) | 00851574 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM (175 MG) | 00851566 | Cancelled Post Market | Hospira Healthcare Corporation | Aug 2012 |
| AMINOSYN-PF 10% (385 MG) | 00731366 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| AMINOSYN-PF 7% (270 MG) | 00731358 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2016 |
| ANTACID 2 TABLETS (61 MG) | 01904310 | Cancelled Post Market | Advertising Unlimited Inc. (A.U.I.) | Feb 2010 |
| BIOCID (20 MG) | 00712493 | Cancelled Post Market | Ayerst Veterinary Laboratories | Aug 2005 |
| CALF PRO (6.756 G) | 02521024 | Cancelled Pre Market | Matrix Environmental Solutions Ltd | Jun 2026 |
| CALF-LYTE (9.37 %) | 01922718 | Cancelled Post Market | Quali-Tech Inc. | Feb 1997 |
| CALF-LYTE II HE PWS (6.756 G) | 02091577 | Cancelled Post Market | Austin, Division Of Vétoquinol N.-A. Inc. | Sep 2000 |
| CALF-LYTE II PWS (6.756 G) | 02011638 | Cancelled Post Market | Austin, Division Of Vétoquinol N.-A. Inc. | Sep 2000 |
| CENTRAHEMO INJ (20 MG) | 01944215 | Cancelled Post Market | Bexco Pharma Inc. | Sep 1996 |
| CENTRAPLEX INJ (20 MG) | 00637254 | Cancelled Post Market | Centravet Products | Aug 1997 |
| CICATRIN POWDER (10 MG) | 00666173 | Cancelled Post Market | Glaxosmithkline Inc | Jan 2009 |
| CLINIMIX (1.04 G) | 02013959 | Cancelled Post Market | Baxter Corporation | Jun 2018 |
| CLINIMIX (880 MG) | 02013916 | Cancelled Post Market | Baxter Corporation | Jul 2016 |
| CLINIMIX (880 MG) | 02013924 | Cancelled Post Market | Baxter Corporation | Jul 2016 |
| CLINIMIX (515 MG) | 02142260 | Cancelled Post Market | Baxter Corporation | Dec 2022 |
| CLINIMIX (515 MG) | 02142279 | Cancelled Post Market | Baxter Corporation | Apr 2022 |
| CLINIMIX 2.5% TRAVASOL AA WITHOUT ELECTROLYTES IN 10% DEXTROSE INJEC (260 MG) | 02142333 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| CLINIMIX E (880 MG) | 02014025 | Cancelled Post Market | Baxter Corporation | Jun 2018 |
| CLINIMIX E (1.04 G) | 02014084 | Cancelled Post Market | Baxter Corporation | Jul 2016 |
| CLINIMIX E (880 MG) | 02014041 | Cancelled Post Market | Baxter Corporation | Jun 2018 |
| CLINIMIX E (1.04 G) | 02014068 | Cancelled Post Market | Baxter Corporation | Mar 2021 |
| CLINIMIX E (515 MG) | 02142341 | Cancelled Post Market | Baxter Corporation | Jun 2018 |
| CLINIMIX E (515 MG) | 02142376 | Cancelled Post Market | Baxter Corporation | Jun 2022 |
| D-LITE - PWR ORL (6.756 G) | 02228661 | Cancelled Post Market | Dispar, Division Of Vétoquinol N.-A. Inc. | Aug 1999 |
| ELECTROLYTE-F-CALF (6.756 G) | 02141558 | Cancelled Post Market | Can-Vet Animal Health Supplies Ltd. | Dec 2017 |
| ELECTROYLTE-F-CALF HE (6.006 G) | 02276925 | Cancelled Post Market | Can-Vet Animal Health Supplies Ltd. | Dec 2017 |
| EQUINE-O-LYTE POWDER (12 G) | 00808172 | Cancelled Post Market | Jim Lewis Agri-Nutrition (1984) Inc. | Sep 2011 |
| GLYCINE IRRIGATION 1.5% USP (1.5 %) | 01963945 | Cancelled Post Market | B. Braun Medical AG | Apr 2021 |
| HB INJECTION (20 MG) | 00807524 | Cancelled Post Market | Bexco Pharma Inc. | Aug 2012 |
| HEMO-15 (20 MG) | 01944010 | Cancelled Post Market | Vetoquinol N A Inc | Aug 2019 |
| HEMO-PLUS LIQ (20 MG) | 02045192 | Cancelled Post Market | Dispar, Division Of Vétoquinol N.-A. Inc. | Aug 2003 |
| HYDRA (9.44 G) | 00564702 | Cancelled Post Market | Vetrepharm Canada Inc. | Jul 2007 |
| ION AID (17.98 G) | 00563919 | Cancelled Post Market | Syntex Animal Health, Division Of Syntex Inc. | Aug 2000 |
| LIFE GUARD H E PWS (4.72 G) | 01915479 | Cancelled Post Market | Smithkline Beecham Animal Health | Jul 2000 |
| LIFE GUARD ORAL (3.12 %) | 00434620 | Cancelled Post Market | Norden Laboratories Inc. | Sep 1996 |
| LIFE GUARD PWS TWIN-PAK (3.12 %) | 01920979 | Cancelled Post Market | Smithkline Beecham Animal Health | Aug 1999 |
| LIFE PAK (3.12 %) | 00568600 | Cancelled Post Market | Vetcom 1979 Inc. | Jul 2009 |
| LIFE-GUARD H.E. PWR (2.88 %) | 00725064 | Cancelled Post Market | Norden Laboratories Inc. | Sep 1996 |
| NUTRINEAL PD4 (51 MG) | 02230810 | Cancelled Post Market | Baxter Corporation | Nov 2021 |
| OLIMEL 3.3% E (2.28 G) | 02352508 | Cancelled Pre Market | Baxter Corporation | Oct 2025 |
| OLIMEL 4.4% (3.07 G) | 02352524 | Cancelled Post Market | Baxter Corporation | Oct 2025 |
| OLIMEL 4.4% E (3.07 G) | 02352516 | Cancelled Post Market | Baxter Corporation | Oct 2025 |
| ORALYTES PCK-PWS (6.006 G) | 02047683 | Cancelled Post Market | P.V.U., Division Of Vétoquinol N.-A. Inc. | Aug 2001 |
| ORALYTES-HE - PWR (6.006 G) | 02223910 | Cancelled Post Market | P.V.U., Division Of Vétoquinol N.-A. Inc. | Aug 2001 |
| ORALYTES-HE PWS (6.006 G) | 01948350 | Cancelled Post Market | Sanofi Santi Animale | Sep 1997 |
| PIG 95 SOW MILK BOOSTER WITH F2G (11.5 %) | 00701882 | Cancelled Post Market | Schuyler Laboratories Inc. | Apr 2003 |
| PRIMENE 10%-LIQ IV (400 MG) | 02161192 | Cancelled Post Market | Clintec Nutrition Company | Aug 1998 |
| PRO-LYTE (9.37 %) | 00766321 | Cancelled Post Market | Quali-Tech Inc. | Feb 1997 |
| QUICK MIX 2.5% TRAVASOL AA WITH ELECTROLYTES WITH 25% DEXTROSE INJEC (520 MG) | 02013983 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Jul 2000 |
| RE-SORB ORAL HYDRATION, ELECTROLYTE PRODUCT (6.36 G) | 02006936 | Cancelled Post Market | Smithkline Beecham Animal Health | Sep 1996 |
| RENAMIN (AMINO ACIDS) INJECTION (300 MG) | 02020564 | Cancelled Post Market | Baxter Corporation | May 2011 |
| STERILE DILUENT FOR FLOLAN INJECTION (94 MG) | 02230857 | Cancelled Post Market | Glaxosmithkline Inc | Nov 2017 |
| TRAVASOL (2.08 G) | 00388769 | Cancelled Post Market | Baxter Corporation | Aug 2016 |
| TRAVASOL AMINO ACID INJ 5.5% (1.14 G) | 00306444 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| TRAVASOL AMINO ACID INJ 8.5% (1.76 G) | 00306436 | Cancelled Post Market | Baxter Corporation | Mar 2008 |
| TRAVASOL E (2.08 G) | 00285528 | Cancelled Post Market | Baxter Corporation | Oct 2017 |
| TRAVASOL INJ WITHOUT ELECTROLYTES 5.5% (1.14 G) | 00388742 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| TRAVASOL INJ WITHOUT ELECTROLYTES 8.5% (1.76 G) | 00388750 | Cancelled Post Market | Baxter Corporation | Mar 2008 |
| UNI PLEX 15 INJ (20 MG) | 00613932 | Cancelled Post Market | Univet Pharmaceuticals Ltd. | Jun 2023 |
| VAMIN 18 ELECTROLYTE-FREE (790 MG) | 02059711 | Cancelled Post Market | Fresenius Kabi Ag | Jul 2006 |
| VAMIN N (210 MG) | 02065665 | Cancelled Post Market | Fresenius Kabi Ag | Jul 2006 |
| VITAMASTER-NF (20 MG) | 02303868 | Cancelled Post Market | Vetoquinol N A Inc | Sep 2020 |